ABSCIENCES (EPA:AB) | WebDisclosure

Basculer en Français

10799	Companies
233612	Keywords
162287	Articles
124730	Press releases

Home
Companies
ABSCIENCES

PRESS RELEASE

published on 07/08/2024 at 07:56, 2 years ago

AB Science annonce des résultats positifs de son étude de Phase 2 évaluant le masitinib dans la Covid-19
AB Science annonce des résultats positifs de son étude de phase 2 évaluant le masitinib dans la COVID-19. Les analyses montrent un potentiel traitement prometteur pour les patients hospitalisés

COVID-19 Traitement Étude De Phase 2 AB Science Masitinib
BRIEF

published on 06/28/2024 at 12:36, 2 years 1 month ago

AB Science fait le point sur la demande d'autorisation du masitinib dans la SLA

Autorisation De Mise Sur Le Marché AB Science Masitinib EMA SLA
BRIEF

published on 06/28/2024 at 12:36, 2 years 1 month ago

AB Science provides an update on the application for authorization of masitinib in ALS

ALS AB Science Masitinib EMA Marketing Authorization
PRESS RELEASE

published on 06/28/2024 at 12:31, 2 years 1 month ago

AB Science fait le point sur la demande d'autorisation de mise sur le marché conditionnelle du masitinib dans la SLA
AB Science annonce un avis négatif sur la demande de mise sur le marché du masitinib dans la SLA et prévoit un réexamen du dossier. Détails sur les raisons et les prochaines étapes

AB Science Masitinib Sclérose Latérale Amyotrophique Autorisation Conditionnelle Réexamen Dossier
PRESS RELEASE

published on 06/28/2024 at 12:31, 2 years 1 month ago

AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS
AB Science receives negative opinion from CHMP on masitinib's conditional marketing authorization for ALS treatment but plans re-examination due to urgent patient need and safety considerations

AB Science Masitinib CHMP ALS Treatment Conditional Marketing Authorization
BRIEF

published on 06/27/2024 at 10:20, 2 years 1 month ago

AB Science - Résultats de l'Assemblée Générale Mixte du 26 juin 2024

Actionnaires Capital Social Assemblée Générale Resolutions AB Science
BRIEF

published on 06/27/2024 at 10:20, 2 years 1 month ago

AB Science - Results of the Combined General Meeting of June 26, 2024

Shareholders Share Capital Resolutions General Assembly AB Science
PRESS RELEASE

published on 06/27/2024 at 10:15, 2 years 1 month ago

AB Science - Résultats de l'Assemblée Générale Mixte du 26 juin 2024
Assemblée Générale Mixte de AB Science du 26 juin 2024 : toutes les résolutions ordinaires et extraordinaires adoptées sauf une. Actionnariat présent : 21.948.183 actions ordinaires et 38.495.615 droits de vote

Actionnaires Droits De Vote Assemblée Générale Resolutions AB Science
BRIEF

published on 05/17/2024 at 18:03, 2 years 2 months ago

Correction des Comptes Consolidés de AB Science pour 2023

Résultats Financiers Recherche Et Développement Comptes Consolidés AB Science Correction Comptable
BRIEF

published on 05/17/2024 at 18:03, 2 years 2 months ago

Correction of the Consolidated Accounts of AB Science for 2023

Financial Results Research And Development Consolidated Accounts AB Science Accounting Correction

Accesswire

Published on 08/04/2026 at 22:30, 1 hour 53 minutes ago

Nextech3D.ai Provides Update on Acquisition of Remaining ARway Shares
Published on 08/04/2026 at 22:00, 2 hours 23 minutes ago

Lockheed Martin and NioCorp Sign MOU
Published on 08/04/2026 at 17:00, 7 hours 23 minutes ago

Moderna annonce le début d'un essai clinique de phase 1 portant sur l’ARNm-1469, son vaccin expérimental contre l'ébolavirus de Bundibugyo
Published on 08/04/2026 at 16:25, 7 hours 58 minutes ago

ACCESS Newswire to Host Second Quarter Earnings Conference Call on August 11, 2026
Published on 08/04/2026 at 15:00, 9 hours 23 minutes ago

Infield Minerals Expands Land Position at the Kings Canyon Gold Project in Utah

View all ACCESSWIRE

EQS Group

Published on 08/04/2026 at 22:03, 2 hours 19 minutes ago

#FutureFresenius: Excellent Q2 performance demonstrates structural step-up – Guidance raised
Published on 08/04/2026 at 22:01, 2 hours 22 minutes ago

EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius raises its earnings guidance for fiscal year 2026 due to strong operational business performance
Published on 08/04/2026 at 20:05, 4 hours 18 minutes ago

Hard Rock Cafe and Coca-Cola® Launch Hard Rock Rising Music Competition for Emerging Artists
Published on 08/04/2026 at 19:40, 4 hours 43 minutes ago

NNS acquires shares in OCI
Published on 08/04/2026 at 19:39, 4 hours 43 minutes ago

EQS-Adhoc: Basler AG financial results for the first 6 months of 2026: Strong business performance in the first half of the year; company raises its 2026 forecast once again

Les Echos

Published on 08/04/2026 at 19:16, 5 hours 7 minutes ago

Covivio - 2026 Half-year financial report
Published on 08/04/2026 at 19:16, 5 hours 7 minutes ago

Covivio - Rapport financier semestriel 2026
Published on 08/04/2026 at 18:32, 5 hours 50 minutes ago

Capital et droits de vote au 31 juillet 2026
Published on 08/04/2026 at 18:32, 5 hours 50 minutes ago

Total number of voting rights and shares making up the share capital at July 31, 2026
Published on 08/04/2026 at 17:45, 6 hours 38 minutes ago

INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE